Revenue segments as reported by the company.

Cannabis revenue

Distribution revenue

Beverage alcohol revenue

Wellness revenue

Adult-use

Canada - Medical

International - Medical

Bulk

Hemp

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Impairment of Assets

Litigation settlement

Transaction costs

Change in fair value of contingent consideration

Restructuring costs

Other than temporary change in fair value of convertible notes receivable

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Tilray Brands

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America. The firm is focused on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment consists of hemp seed, hemp foods, and broad spectrum hemp extract containing CBD, which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Earnings data Q1 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Tilray Brands reports record revenue and optimistic outlook for 2025

Tilray Brands achieved remarkable financial performance in Q4 2024, driven by strategic acquisitions and a focus on innovation. Despite challenges like price compression, the company remains optimistic about future growth opportunities. Tilray's commitment to quality products and innovation positions it well for continued success in the market.

Tilray Brands reports record Q1 revenue growth and global expansion

Tilray Brands delivered a robust performance in Q1 2025, showcasing strong revenue growth, margin improvement, and strategic expansion across its diversified product portfolio.
While facing challenges in a competitive landscape and evolving regulatory environment, Tilray's financial strength, international growth initiatives, and focus on innovation position it well for future success.
By capitalizing on opportunities in wellness products, expanding into new beverage categories, and leveraging strategic partnerships, Tilray is poised for continued growth and market leadership.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. The Cannabis Business segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution Business segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage Alcohol Business segment refers to the production, marketing, and sale of beverages. The Wellness Business segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Aurora Cannabis

HEXO Corp

Hexo has a plan to get bigger -- but it could cause cash profits to get smaller.

Why Hexo, Tilray, and Aurora Cannabis Got Smoked Tuesday

Tilray Expands Medical Cannabis Product Offering in Australia Tilray Brands, Inc. (“Tilray”… The post Tilray Brands, Inc. (TLRY) Expands Medical Cannabis Product Offering in Australia appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Tilray Brands, Inc. (TLRY) Expands Medical Cannabis Product Offering in Australia

Marijuana giant Tilray Brands, Inc. (NASDAQ:TLRY) (TSX:TLRY) announced on Tuesday the expansion of its medical cannabis product offering in Australia and the launch of a new medical cannabis e-learning platform for healthcare providers. “Tilray is transforming the industry globally with our highly scalable footprint and portfolio of diverse cannabis products,” stated Denise Faltischek, head of international and chief strategy officer.

Tilray Expands Medical Marijuana Product Offering In Australia, Launches Cannabis E-Learning Platform

Village Farms International

Best Canadian Pot Stocks To Watch In 2022 The post Best Canadian Marijuana Stocks To Buy? 2 To Watch In 2022 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Best Canadian Marijuana Stocks To Buy? 2 To Watch In 2022

Is it a hint that the company will fall short of its forecast?

Tilray's CEO Made a Surprising Prediction on the Company's Latest Earnings Call

Canopy Growth

OrganiGram Holdings Inc.

The legal cannabis industry in Canada must continue to consolidate to make it an attractive space for investors.

This Megamerger Might Be Required Before Canadian Cannabis Stocks Can Rebound

Tilray has high costs to overcome first as it builds its brand recognition in the U.S. market and ahead of the Federal cannabis legalization. The post Why TLRY Stock Is at a Positive Turning Point appeared first on InvestorPlace.

Why TLRY Stock Is at a Positive Turning Point

The company posted a profit in its most recent quarter -- but just how impressive was the result?

3 Charts That Sum Up Tilray's Q2 Earnings

Chevron

Marathon Digital Holdings

Pfizer

PayPal

Target

XPeng

Long-term stocks that promise to be value creators with a robust business model and positive industry tailwinds. Companies that are positioned for robust free cash flows.

7 Long-Term Stocks to Buy and Hold Until 2030

Anheuser-Busch InBev

Flora Growth Corp

GrowGeneration Corp

Welcome back to our weekly series,  Schaeffer's Cannabis Stock News Update , where we recap what happened in the world of marijuana stocks, and look at how the cannabis industry is shaping up as we kick off 2022.

Which Cannabis Stock Dominated Sector Headlines This Week

SNDL Inc.

On today's Cannabis Daily host Elliot Lane shares his top Cannabis Stock Picks for 2022. His categories include: Long term Growth Stocks

Top Cannabis Stocks To Have On Your Watchlist in 2022

TLRY stock jumped following a strong earnings report. Here's why it's finally time to trust in this cannabis turnaround story.

Why Tilray Stock Is Starting to Look Interesting

Amplify Seymour Cannabis ETF

Amplify Alternative Harvest ETF

AdvisorShares Pure US Cannabis ETF

Global X Cannabis ETF

AdvisorShares Pure Cannabis ETF 

Cannabis stocks and ETFs were massively downbeat in 2021. However, strong sales backdrop, growing medical usage and still-alive chances of a federal approval may cause a bounce back in pot ETFs in 2022.

After a Downbeat 2021, Will Marijuana ETFs Rebound in 2022?

As the first cannabis company to enter the U.S. alcohol market Tilray is breaking ground that could see the worlds of pot and alcohol drawing even closer.

Canadian Cannabis Company Tilray Is Merging The Worlds Of Cannabis And Alcohol

QuantumScape

Don't stop believing in bull markets, but be a smarter investor with these three bear markets offering secular growth at deep discounts. The post 3 Bear Markets to Buy as Traders Adjust appeared first on InvestorPlace.

3 Bear Markets to Buy as Traders Adjust

Tilray Inc. (NASDAQ:TLRY) wrapped up two previously announced deals to acquire Green Flash Brewing and Alpine Beer Co. The Canadian cannabis giant purchased the California craft beer brands from WC IPA on Dec. 17, for $5.1 million (CA$6.4 million), in cash and stock, according to the filing with the U.S. Securities and Exchange Commission (SEC).

Tilray Buys Two California Craft Beer Brands For $5.1M

Consecutive days of solid earnings in the Canadian cannabis sector has investors feeling better.

Why Tilray, Organigram, and Hexo Stocks Bounced Today

Analysts might not be enamored with TLRY stock, but Tilray is venturing into some interesting and potentially lucrative market niches. The post Embrace the Weakness and Expect Growth for Tilray appeared first on InvestorPlace.

Embrace the Weakness and Expect Growth for Tilray

In a recent analyst note, Pablo Zuanic from Cantor Fitzgerald offered an updated investment model for Tilray Inc. (NASDAQ:TLRY) in which he maintained an Overweight but lowered the price target for the stock to $6.90 from $7.40 on reduced estimates. The Thesis

Tilray's Growth In Export Business 'Positively' Impresses Analyst, Maintains Overweight

Tilray reported net income, positive EBITDA, and positive EPS.

Tilray Rallies 20% Early Morning On Improved Q2-2022 Financial Performance

The stock price of Tilray Inc (NASDAQ: TLRY) increased by 13.55% in the most recent trading session. This is why it happened.

Tilray Stock (TLRY): Why The Price Jumped

Cannabis companies mainly invest in medical and recreational marijuana. However, more segments continue to emerge in the industry including CBD oils and industrial hemp, among others.

Are these the best cannabis stock to buy in 2022?

Tilray, Inc. (TLRY) CEO Irwin Simon on Q2 2022 Results - Earnings Call Transcript

Intel

NVIDIA

Roku

Roku, Tilray, Nvidia and Intel were our top stock trades for Tuesday. With that in mind, let's look at how the charts are setting up now.

4 Top Stock Trades for Tuesday: ROKU, TLRY, NVDA, INTC

The world's leading brewer, AB InBev, and Tilray have ended their partnership, reported MJBizDaily. When Tilray first announced the partnership in 2018, the two companies had pledged to invest $50 million in the venture, called Fluent Beverage Co. Each company had a 50% ownership interest.

Tilray And Budweiser Maker AB InBev Call Off Cannabis Beverage Partnership

News for Tilray Brands Stock (TLRY)